Stocks US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug July 6, 2023 0 Post ContentPost Content Post navigation Previous article FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage Next article Explainer-Who is eligible for the new FDA-approved Alzheimer’s drug?
Big tech is spending billions on AI. How much time will Wall Street allow for the payoff? January 26, 2025
‘Her crooked son has taken everything’: My fiancé’s 100-year-old aunt was swindled out of $100,000. How can we help? January 25, 2025
The Social Security Fairness Act is a terrible piece of legislation — here’s how to fix the problem January 25, 2025
